Search
Marketing Approval Granted for World's First Hexavalent Rotavirus Vaccine
2025-08-22 /
Read about 0 minute
Author：小编
Recently, the oral hexavalent reassortant rotavirus attenuated live vaccine (produced using Vero cells), trademarked as Wushenerlunbao®, developed by the Wuhan Institute of Biological Products under China National Biotech Group, has officially received marketing approval. This groundbreaking vaccine stands as the world's first rotavirus vaccine with the highest valence and is classified as a Class 1 new biological product for preventive use in China. It is specifically designed to safeguard infants and young children against acute gastroenteritis caused by rotavirus, offering a novel vaccination alternative to the targeted population.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
